<DOC>
	<DOCNO>NCT00998257</DOCNO>
	<brief_summary>The objective Post Marketing Surveillance ( PMS ) gain information safety efficacy real practice .</brief_summary>
	<brief_title>Regulatory Post Marketing Surveillance Study YAZ</brief_title>
	<detailed_description />
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<criteria>Healthy female subject request contraception suggest PMDD Physician also request contraception acne also request contraception Age : 18 50 year Women prescribe YAZ first , study period Women contraindicate base label YAZ Presence history venous arterial thrombotic/ thromboembolic event ( e.g . deep venous thrombosis , pulmonary embolism , myocardial infarction ) cerebrovascular accident Presence history prodromi thrombosis ( e.g . transient ischaemic attack , angina pectoris ) History migraine focal neurological symptom Diabetes mellitus vascular involvement The presence severe multiple risk factor ( ) venous arterial thrombosis may also constitute contraindication Pancreatitis history thereof associate severe hypertriglyceridemia Presence history severe hepatic disease long liver function value return normal Severe renal insufficiency acute renal failure Presence history liver tumour ( benign malignant ) Known suspect sexsteroid influenced malignancy ( e.g . genital organ breast ) Undiagnosed vaginal bleeding Known suspect pregnancy Hypersensitivity active substance excipients</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Premenstrual Dysphoric Disorder</keyword>
	<keyword>PMDD</keyword>
	<keyword>Acne</keyword>
</DOC>